BACKGROUND: More frequent patient-provider encounters may lead to faster control of hemoglobin A1c level, blood pressure (BP), and low-density lipoprotein (LDL) cholesterol (LDL-C) level (hereafter referred to as hemoglobin A1c, BP, and LDL-C) and improve outcomes, but no guidelines exist for how frequently patients with diabetes mellitus (DM) should be seen. METHODS: This retrospective cohort study analyzed 26,496 patients with diabetes and elevated hemoglobin A1c, BP, and/or LDL-C treated by primary care physicians at 2 teaching hospitals between January 1, 2000, and January 1, 2009. The relationship between provider encounter (defined as a note in the medical record) frequency and time to hemoglobin A1c, BP, and LDL-C control was assessed. RESULTS: Comparing patients who had encounters with their physicians between 1 to 2 weeks vs 3 to 6 months, median time to hemoglobin A1c less than 7.0% was 4.4 vs 24.9 months (not receiving insulin) and 10.1 vs 52.8 months (receiving insulin); median time to BP lower than 130/85 mm Hg was 1.3 vs 13.9 months; and median time to LDL-C less than 100 mg/dL was 5.1 vs 32.8 months, respectively (P<.001 for all). In multivariable analysis, doubling the time between physician encounters led to an increase in median time to hemoglobin A1c (not receiving [35%] and receiving [17%] insulin), BP (87%), and LDL-C (27%) targets (P<.001 for all). Time to control decreased progressively as encounter frequency increased up to once every 2 weeks for most targets, consistent with the pharmacodynamics of the respective medication classes. CONCLUSIONS: Primary care provider encounters every 2 weeks are associated with fastest achievement of hemoglobin A1c, BP, and LDL-C targets for patients with diabetes mellitus.
BACKGROUND: More frequent patient-provider encounters may lead to faster control of hemoglobin A1c level, blood pressure (BP), and low-density lipoprotein (LDL) cholesterol (LDL-C) level (hereafter referred to as hemoglobin A1c, BP, and LDL-C) and improve outcomes, but no guidelines exist for how frequently patients with diabetes mellitus (DM) should be seen. METHODS: This retrospective cohort study analyzed 26,496 patients with diabetes and elevated hemoglobin A1c, BP, and/or LDL-C treated by primary care physicians at 2 teaching hospitals between January 1, 2000, and January 1, 2009. The relationship between provider encounter (defined as a note in the medical record) frequency and time to hemoglobin A1c, BP, and LDL-C control was assessed. RESULTS: Comparing patients who had encounters with their physicians between 1 to 2 weeks vs 3 to 6 months, median time to hemoglobin A1c less than 7.0% was 4.4 vs 24.9 months (not receiving insulin) and 10.1 vs 52.8 months (receiving insulin); median time to BP lower than 130/85 mm Hg was 1.3 vs 13.9 months; and median time to LDL-C less than 100 mg/dL was 5.1 vs 32.8 months, respectively (P<.001 for all). In multivariable analysis, doubling the time between physician encounters led to an increase in median time to hemoglobin A1c (not receiving [35%] and receiving [17%] insulin), BP (87%), and LDL-C (27%) targets (P<.001 for all). Time to control decreased progressively as encounter frequency increased up to once every 2 weeks for most targets, consistent with the pharmacodynamics of the respective medication classes. CONCLUSIONS: Primary care provider encounters every 2 weeks are associated with fastest achievement of hemoglobin A1c, BP, and LDL-C targets for patients with diabetes mellitus.
Authors: Thomas H Lee; Thomas Bodenheimer; Allan H Goroll; Barbara Starfield; Katharine Treadway Journal: N Engl J Med Date: 2008-11-13 Impact factor: 91.245
Authors: Alexander Turchin; Nikheel S Kolatkar; Richard W Grant; Eric C Makhni; Merri L Pendergrass; Jonathan S Einbinder Journal: J Am Med Inform Assoc Date: 2006-08-23 Impact factor: 4.497
Authors: Kwok Leung Ong; Bernard M Y Cheung; Louisa Y F Wong; Nelson M S Wat; Kathryn C B Tan; Karen S L Lam Journal: Ann Epidemiol Date: 2008-01-16 Impact factor: 3.797
Authors: Karen E Hauer; Steven J Durning; Walter N Kernan; Mark J Fagan; Matthew Mintz; Patricia S O'Sullivan; Michael Battistone; Thomas DeFer; Michael Elnicki; Heather Harrell; Shalini Reddy; Christy K Boscardin; Mark D Schwartz Journal: JAMA Date: 2008-09-10 Impact factor: 56.272
Authors: Alexander Turchin; Maria Shubina; Anna H Chodos; Jonathan S Einbinder; Merri L Pendergrass Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Alexander Turchin; Maria Shubina; Eugene Breydo; Merri L Pendergrass; Jonathan S Einbinder Journal: J Am Med Inform Assoc Date: 2009-03-04 Impact factor: 4.497
Authors: M Marre; J Shaw; M Brändle; W M W Bebakar; N A Kamaruddin; J Strand; M Zdravkovic; T D Le Thi; S Colagiuri Journal: Diabet Med Date: 2009-03 Impact factor: 4.359
Authors: David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert Sherwin; Bernard Zinman Journal: Diabetes Care Date: 2008-10-22 Impact factor: 17.152
Authors: Sohail Rana; Patricia E Houston; Winfred C Wang; Rathi V Iyer; Jonathan Goldsmith; James F Casella; Caroline K Reed; Zora R Rogers; Myron A Waclawiw; Bruce Thompson Journal: Pediatrics Date: 2014-09 Impact factor: 7.124
Authors: Amy G Huebschmann; Trina Mizrahi; Alyssa Soenksen; Brenda L Beaty; Thomas D Denberg Journal: J Clin Hypertens (Greenwich) Date: 2012-03-16 Impact factor: 3.738
Authors: Sybil G Hosek; Bret Rudy; Raphael Landovitz; Bill Kapogiannis; George Siberry; Brandy Rutledge; Nancy Liu; Jennifer Brothers; Kathleen Mulligan; Gregory Zimet; Michelle Lally; Kenneth H Mayer; Peter Anderson; Jennifer Kiser; James F Rooney; Craig M Wilson Journal: J Acquir Immune Defic Syndr Date: 2017-01-01 Impact factor: 3.731
Authors: Kevin F Erickson; Kelvin B Tan; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya Journal: Clin J Am Soc Nephrol Date: 2013-02-21 Impact factor: 8.237
Authors: Keiko Asao; Laura N McEwen; Jesse C Crosson; Beth Waitzfelder; William H Herman Journal: J Diabetes Complications Date: 2014-06-19 Impact factor: 2.852
Authors: Steven M Smith; Nicholas W Carris; Eric Dietrich; John G Gums; Liz Uribe; Christopher S Coffey; Tyler H Gums; Barry L Carter Journal: J Am Soc Hypertens Date: 2016-01-18
Authors: Kevin Fiscella; Gbenga Ogedegbe; Hua He; Jennifer Carroll; Andrea Cassells; Mechelle Sanders; Chamanara Khalida; Brianna D'Orazio; Jonathan N Tobin Journal: Am Heart J Date: 2015-09-12 Impact factor: 4.749